NCT06454708View on ClinicalTrials.gov

Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 12, 2024

Study Completion Date

August 12, 2024

Conditions
Acne Vulgaris
Interventions
DRUG

Clascoterone Cream 1%

Clascoterone Cream 1% (Winlevi) is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

Trial Locations (1)

N1 9JP

Huashan Hospital, Fudan University, London

All Listed Sponsors
lead

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.

INDUSTRY

NCT06454708 - Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects | Biotech Hunter | Biotech Hunter